129 related articles for article (PubMed ID: 32578212)
1. Emergence of lymphomatoid papulosis during treatment with brentuximab vedotin.
Mansoor N; McKenna L; Molloy O; Smyth E; Flavin R; Ryan C; Quinn J; Roche M
Int J Dermatol; 2020 Sep; 59(9):e332-e334. PubMed ID: 32578212
[No Abstract] [Full Text] [Related]
2. Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.
Lewis DJ; Talpur R; Huen AO; Tetzlaff MT; Duvic M
JAMA Dermatol; 2017 Dec; 153(12):1302-1306. PubMed ID: 28980004
[TBL] [Abstract][Full Text] [Related]
3. A rare case of early-onset lymphomatoid papulosis refractory to brentuximab vedotin.
Ferranti M; Salmaso R; Marino D; Alaibac M
Dermatol Ther; 2021 May; 34(3):e14943. PubMed ID: 33719147
[No Abstract] [Full Text] [Related]
4. Lymphomatoid papulosis and fingolimod-A new connection?
Cohen V; Saber M; Provost N; Friedmann D
Mult Scler; 2016 Oct; 22(12):1629-1630. PubMed ID: 26993118
[No Abstract] [Full Text] [Related]
5. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Samaraweera AP; Cohen SN; Akay EM; Evangelou N
Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
[TBL] [Abstract][Full Text] [Related]
6. Tattoos and coincidental skin conditions: the example of lymphomatoid papulosis.
Kluger N
Br J Dermatol; 2014 Dec; 171(6):1561. PubMed ID: 24841722
[No Abstract] [Full Text] [Related]
7. Lymphomatoid papulosis and FK 506.
Siddiqui MA; Sullivan S; al-Mofadhi AM
Int J Dermatol; 1997 Mar; 36(3):202-5. PubMed ID: 9159004
[No Abstract] [Full Text] [Related]
8. Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Matoula T; Nikolaou V; Marinos L; Katsavos S; Nasis G; Economidi A; Karampidou K; Stratigos A; Antoniou C
Mult Scler; 2016 Oct; 22(12):1630-1631. PubMed ID: 27053634
[No Abstract] [Full Text] [Related]
9. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum responding to ciclosporin without adverse effects in a patient with lymphomatoid papulosis.
Busick TL; Bennett DD; Cohen JB
Clin Exp Dermatol; 2010 Dec; 35(8):918-9. PubMed ID: 20456406
[No Abstract] [Full Text] [Related]
11. CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma?
Haus G; Utikal J; Geraud C; Goerdt S; Leverkus M
Br J Dermatol; 2014 Sep; 171(3):668-70. PubMed ID: 24689991
[No Abstract] [Full Text] [Related]
12. Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.
Park JH; Lee J; Lee JH; Lee DY; Koh EM
Dermatology; 2012; 225(3):259-63. PubMed ID: 23257839
[TBL] [Abstract][Full Text] [Related]
13. [Management of mycosis fungoide : focus on brentuximab vedotin].
Lebas E; Collins P; Bonnet C; Libon F; Dezfoulian B; Nikkels AF
Rev Med Liege; 2021 Apr; 76(4):224-231. PubMed ID: 33830684
[TBL] [Abstract][Full Text] [Related]
14. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
Trager MH; Chen C; Husain S; Geskin LJ
J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid for lymphomatoid papulosis.
Champagne T; Walsh S
J Cutan Med Surg; 2013; 17(5):332-4. PubMed ID: 24067853
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.
Dummer R; Prince HM; Whittaker S; Horwitz SM; Kim YH; Scarisbrick J; Quaglino P; Zinzani PL; Wolter P; Eradat H; Pinter-Brown L; Sanches JA; Ortiz-Romero PL; Akilov OE; Geskin L; Huen A; Walewski J; Wang Y; Lisano J; Richhariya A; Feliciano J; Zhu Y; Bunn V; Little M; Zagadailov E; Dalal MR; Duvic M
Eur J Cancer; 2020 Jul; 133():120-130. PubMed ID: 32502876
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of lymphomatoid papulosis type E with extensive necrosis.
Pindado-Ortega C; Fonda-Pascual P; Buendía-Castaño D; Fernández-González P; Peña-Jaimes L; Carrillo-Gijón R
Indian J Dermatol Venereol Leprol; 2018; 84(4):515-517. PubMed ID: 29067932
[TBL] [Abstract][Full Text] [Related]
18. Lymphomatoid papulosis.
Wiznia LE; Cohen JM; Beasley JM; Meehan SA; Latkowski JM
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677799
[TBL] [Abstract][Full Text] [Related]
19. Type A lymphomatoid papulosis presenting as an eyelid ulcer in a young man.
Sánchez España JC; Secondi R
Orbit; 2019 Dec; 38(6):495-499. PubMed ID: 30644803
[TBL] [Abstract][Full Text] [Related]
20. Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.
Goyal A; Patel S; Goyal K; Morgan EA; Foreman RK
J Cutan Pathol; 2019 Nov; 46(11):823-829. PubMed ID: 31286556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
